Comparative Pharmacology
Head-to-head clinical analysis: ACLOVATE versus FLUTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACLOVATE versus FLUTEX.
ACLOVATE vs FLUTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aclovate (alclometasone dipropionate) is a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Its mechanism involves binding to glucocorticoid receptors, modulating gene expression to inhibit phospholipase A2, reducing arachidonic acid release, and decreasing prostaglandin and leukotriene synthesis.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
Apply a thin film to affected skin areas twice daily. Not for ophthalmic, oral, or intravaginal use.
50 mg orally once daily
None Documented
None Documented
Terminal elimination half-life: approximately 6-8 hours after topical application; systemic absorption is minimal under normal use.
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Renal (primarily as metabolites, <5% unchanged), biliary/fecal (minor).
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid